0000880771-17-000101.txt : 20170609
0000880771-17-000101.hdr.sgml : 20170609
20170609162829
ACCESSION NUMBER: 0000880771-17-000101
CONFORMED SUBMISSION TYPE: 4
PUBLIC DOCUMENT COUNT: 1
CONFORMED PERIOD OF REPORT: 20170608
FILED AS OF DATE: 20170609
DATE AS OF CHANGE: 20170609
ISSUER:
COMPANY DATA:
COMPANY CONFORMED NAME: SCICLONE PHARMACEUTICALS INC
CENTRAL INDEX KEY: 0000880771
STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834]
IRS NUMBER: 943116852
STATE OF INCORPORATION: DE
FISCAL YEAR END: 1231
BUSINESS ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
BUSINESS PHONE: 650-358-3456
MAIL ADDRESS:
STREET 1: 950 TOWER LANE
STREET 2: SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
REPORTING-OWNER:
OWNER DATA:
COMPANY CONFORMED NAME: Hawkins Richard J
CENTRAL INDEX KEY: 0001307632
FILING VALUES:
FORM TYPE: 4
SEC ACT: 1934 Act
SEC FILE NUMBER: 000-19825
FILM NUMBER: 17903285
MAIL ADDRESS:
STREET 1: 950 TOWER LANE, SUITE 900
CITY: FOSTER CITY
STATE: CA
ZIP: 94404-2125
4
1
certent-form4.xml
PRIMARY DOCUMENT
X0306
4
2017-06-08
0000880771
SCICLONE PHARMACEUTICALS INC
SCLN
0001307632
Hawkins Richard J
950 TOWER LANE, SUITE 900
FOSTER CITY
CA
94404
1
0
0
1
Board Member
Non-Qualified Stock Option (right to buy)
10.9
2017-06-08
4
A
0
30000
0
A
2027-06-08
Common Stock
30000
30000
D
Granted under the Issuer's 2015 Equity Incentive Plan.
Each option shall vest and become exercisable at the rate of one-twelfth of the shares subject to the option at the end of each one-month period from the date of grant except that, in the event of a change in control, any unexercisable or unvested portions of outstanding options shall be immediately exercisable and vested in full as of the date ten (10) days prior to the change in control, regardless of whether the option is assumed or substituted for by the acquirer.
/s/ Wilson W. Cheung, Attorney-in-Fact For: Richard J. Hawkins
2017-06-09